|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Portfolio Management Strategy
Cutting Edge Information, May 2006, Pages: 179
This latest study delves into the challenges facing pharmaceutical portfolio management teams. As one of the most important components to strategic planning, portfolio management is often left neglected or under-resourced. As many as 82% of pharmaceutical companies believe that their portfolio management successes have been adequate at best. Two-thirds of companies believe that their portfolio management function is lacking resources.
It is no surprise then that many companies struggle with how they will strategically invest in their portfolio products, how to coordinate activities and when to make the decision to cease development in underperforming projects.
Among the many findings that analysts discovered through this research, several strategies and industry trends emerged as more significant, including:
- Portfolio management delivers the strongest impact when aligned with corporate strategy
- Mid-sized companies face the greatest portfolio management challenges as they grow larger
- Data standardization, though difficult to achieve, streamlines portfolio management and makes the decision-making process more effective
- Participating companies cited corporate culture and lack of buy-in as the greatest barriers to portfolio management success
- An inverse relationship exists between the frequency of portfolio management team meetings and overall satisfied with portfolio management success
This research was developed to guide pharmaceutical and biotechnology companies’ portfolio management teams. The study includes benchmark data to help portfolio management teams gain adequate resources and understand how best to allocate brand team budgets. The report makes its case with metrics, tools and techniques for managing portfolio planning in these key areas:
Structure, Resources and Tools – Efficient portfolio management structures backed by adequate budgets and staffs allow portfolio planners to obtain required product metrics and make informed recommendations to support the company’s products.
Portfolio Management Strategy – Portfolio planning is rendered useless without clear, standardized criteria with which to compare products. Furthermore, maintaining a consistent portfolio strategy allows companies to find lucrative licensing opportunities that drive create at lower costs.
Portfolio Snapshots – Analysis of participating companies’ portfolios, including strengths, weaknesses and areas of interest for future growth.
Customers who bought this item also bought
Pharmaceutical Alliance Management
Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs
Benchmarking Drug Safety and Pharmacovigilance
Evolving Medical Information Call Centers through Performance Measurement and Process Improvement
Business Development: Accelerating the Deal
Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets
The New "Medical Science Liaisons" Profile: Internal Thought Leader, External Voice and Clinical Catalyst
Pharmaceutical and Medical Device Regulatory Affairs
Best Practices in MSL Team Management: Benchmarks for Team Staffing, Budgets and Structure
The Toolkit for Diabetes MSL Programs
Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships
Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI
|
|
|
|
